CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Open-market sale EVP, Commercial sold 34,387 shares at $44.06 ($1,515,091)
- 4 Open-market sale Director sold 4,544 shares at $44.29 ($201,254)
- 4 Open-market sale Director sold 20,634 shares at $45.99 ($948,958)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 30,693 shares (to pay taxes)
- 4 Open-market sale EVP and CFO sold 100,000 shares at $46.00 ($4,600,000)
- 4 Open-market sale Director sold 36,508 shares at $44.35 ($1,619,130)
- 4 Shares withheld for taxes President and CEO gave up 325,263 shares (to pay taxes)
- 4 Open-market sale EVP & General Counsel sold 25,000 shares at $46.18 ($1,154,500)
- 4 Planned sale EVP, Commercial sold 136,383 shares at an average $47.58 ($6,488,503)
- 4 Open-market sale EVP Prod Dev & Med Aff & CMO sold 72,776 shares at $45.47 ($3,309,125)
- 4 Planned sale CSO/EVP Disc & Trans Research sold 1,508 shares at $39.00 ($58,812)
- 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 159,383 shares (grant or award)
- 4 Grant or award President and CEO acquired 589,719 shares (grant or award)
Page 4 of 73 · 1,458 filings